-
1
Circulating tumour DNA in the evolving treatment landscape of locally advanced rectal cancer: where does it fit in?
Published 2023-03-01“…Therapeutic Advances in Medical Oncology…”
Get full text
Article -
2
Cancer immune profiling unveils biomarkers, immunological pathways, and cell type score associated with glioblastoma patients’ survival
Published 2022-12-01“…Therapeutic Advances in Medical Oncology…”
Get full text
Article -
3
Eribulin combined with antiangiogenic agents in women with HER2-negative metastatic breast cancer: a retrospective multicenter study
Published 2023-10-01“…Therapeutic Advances in Medical Oncology…”
Get full text
Article -
4
Erratum to Immune checkpoint inhibitors or anti-claudin 18.2 antibodies? A network meta-analysis for the optimized first-line therapy of HER2-negative gastric cancer
Published 2024-03-01“…Therapeutic Advances in Medical Oncology…”
Get full text
Article -
5
Personalized treatment with PARP inhibitors in advanced urothelial carcinoma: a case report and literature review
Published 2024-04-01“…Therapeutic Advances in Medical Oncology…”
Get full text
Article -
6
Safety, tolerability, and pharmacokinetics of an anti-LAG-3 antibody SHR-1802 in patients with advanced solid tumors: a phase I dose-escalation and dose-expansion study
Published 2023-07-01“…Therapeutic Advances in Medical Oncology…”
Get full text
Article -
7
Efficacy of immunotherapy in patients with oncogene-driven non-small-cell lung cancer: a systematic review and meta-analysis
Published 2024-02-01“…Therapeutic Advances in Medical Oncology…”
Get full text
Article -
8
Short-term fasting and fasting mimicking diets combined with chemotherapy: a narrative review
Published 2023-03-01“…Therapeutic Advances in Medical Oncology…”
Get full text
Article -
9
Real-world study of hepatic artery infusion chemotherapy combined with anti-PD-1 immunotherapy for hepatocellular carcinoma patients with portal vein tumor thrombus
Published 2024-04-01“…Therapeutic Advances in Medical Oncology…”
Get full text
Article -
10
Combined pre-treatment and middle-treatment Epstein–Barr virus DNA load contributes to prognostication and treatment modification in nasopharyngeal carcinoma patients
Published 2024-01-01“…Therapeutic Advances in Medical Oncology…”
Get full text
Article -
11
Rational and trial design of FASCINATE-N: a prospective, randomized, precision-based umbrella trial
Published 2024-02-01“…Therapeutic Advances in Medical Oncology…”
Get full text
Article -
12
Deficient mismatch repair/microsatellite unstable colorectal cancer: therapeutic advances and questions
Published 2024-01-01“…Therapeutic Advances in Medical Oncology…”
Get full text
Article -
13
Novel systemic therapies in the management of tyrosine kinase inhibitor-pretreated patients with epidermal growth factor receptor-mutant non-small-cell lung cancer
Published 2023-08-01“…Therapeutic Advances in Medical Oncology…”
Get full text
Article -
14
Plasma ddPCR for the detection of amplification in advanced NSCLC patients: a comparative real-world study
Published 2024-02-01“…Therapeutic Advances in Medical Oncology…”
Get full text
Article -
15
TRK inhibitor in a patient with metastatic triple-negative breast cancer and fusions identified cell-free DNA analysis
Published 2023-01-01“…Therapeutic Advances in Medical Oncology…”
Get full text
Article -
16
Chinese expert consensus on clinical practice of MET detection in non-small cell lung cancer
Published 2024-01-01“…Therapeutic Advances in Medical Oncology…”
Get full text
Article -
17
Major adverse cardiovascular events in advanced-stage lung cancer: a multicenter cohort study
Published 2024-01-01“…Therapeutic Advances in Medical Oncology…”
Get full text
Article -
18
Trabectedin and low-dose radiation therapy in patients with advanced leiomyosarcoma
Published 2024-01-01“…Therapeutic Advances in Medical Oncology…”
Get full text
Article -
19
The role of aberrant DNA methylation in cancer initiation and clinical impacts
Published 2024-01-01“…Therapeutic Advances in Medical Oncology…”
Get full text
Article -
20
A prospective phase II single-arm study and predictive factor analysis of irinotecan as third-line treatment in patients with metastatic gastric cancer
Published 2024-02-01“…Therapeutic Advances in Medical Oncology…”
Get full text
Article